News and Trends 28 Jun 2022
Eiger BioPharmaceuticals presents liver study data
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharma company focused on the development of innovative therapies to treat and cure hepatitis delta virus (HDV) and other serious diseases, has announced data presented…